Development of a Bispecific therapeutic antibody for the treatment of metastatic breast cancer
Development of a fully human bispecific therapeutic antibody for T cell mediated eradication of Acute Myeloid Leukemia
Innovating GPCR Drug Discovery with Protein Engineering and Biophysics
Sialylated antigens as immune tolerance inducers: an innovative therapeutic vaccine for MS.
Development of a potent bispecific antibody combination to treat colon cancer with reduced toxicity
Accelerating Drug Design by Automated NMR
A Mass Spectrometry solution for rapid antibiotic susceptibility testing in bloodstream infections
Polypharmacology drug discovery platform to unlock novel chemical space for chemokine therapeutics